Colorectal cancer

• A First-In-Human Trial of the novel T cell Immunotherapy pTTL in Patients with Advanced Colorectal Cancer Recruitment ended
  2024-512296-13-00 1 2023-04-03 "colorectal cancer"
• Phase I, open-label study to evaluate the safety and immune activity of PeptiCRAd-1, an oncolytic virus coated with tumor-specific peptides … Recruitment ended
  2024-517580-23-00 1 2023-03-07 "Sarcoma"
• A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single-Agent and Combination Therapy in Subjects with I … Recruitment ended
  2024-515617-18-00 1 2022-02-14 "Advanced clear cell renal cell carcinoma (ccRCC), non-clear "
• A study of patients with colorectal cancer that have a genetic abnormality in the BRAF gene taking encorafenib plus cetuximab with or withou … Recruitment ended
  2023-509405-77-00 5 2021-02-16 "Colorectal cancer (BRAF V600E-mutant mCRC)"
• STAR-TREC: Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision fo … Recruitment ended
  2024-516106-31-00 10 2017-06-16 "Early stage colorectal cancer"
• A study of PF-08046050 (SGN-CEACAM5C) in adults with advanced solid tumors Halted
  2023-505858-18-00 1 2024-06-28 "Pancreatic carcinoma"
• A phase I/II trial of D,L-MEthadone and mFOLFOX6 in treatment of advanced colorectal cancer (MEFOX) Ended
  2024-519509-37-00 9 2025-02-25 "Patients with advanced, histologically confirmed, metastatic"
• A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-A3 … Ended
  2023-505322-34-00 1 2024-01-08 "Advanced or metastatic solid tumors"
• Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Adv … Ended
  2022-501465-40-00 4 2023-12-22 "Colorectal Cancer"
• AN OPEN-LABEL, MULTICENTER, PHASE 1a/1b STUDY OF IGM-8444 AS A SINGLE AGENT AND IN COMBINATION IN SUBJECTS WITH RELAPSED, REFRACTORY, OR NEW … Ended
  2023-504545-31-00 1 2023-11-23 "colorectal cancer"
• Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors Ended
  2022-502867-39-00 1 2023-09-29 "Advanced solid tumors including non-small cell lung cancer ("
• A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08 , an IL-15 Antibody Fusion Protein Targeting CTLA-4, Mo … Ended
  2024-511750-53-00 7 2022-09-08 "Unresectable Locally Advanced or Metastatic Cancer"
• A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors Ended
  2023-505425-14-00 9 2022-08-11 "colorectal cancer"
• Phase II trial of Pembrolizumab and Olaparib in homologous-recombination deficient (HRD) advanced colorectal cancer (CRC). Ended
  2023-509095-42-00 4 2022-07-14
• A Phase 1 open-label, first-in-human, multi-center, dose escalation and dose expansion study of CLN-619 administered alone or in combination … Ended
  2024-511744-27-00 1 2022-06-27 "Solid tumors, Non-Small Cell Lung Cancer, Cervical Cancer, E"
• A study of safety and efficacy of novel targeted therapy combinations in adult patients with advanced or metastatic colorectal cancer. Ended
  2023-510379-77-00 3 2020-08-05 "Advanced or metastatic BRAF V600 colorectal cancer."
• A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selecte … Ended
  2024-513915-28-00 3 2019-06-14 "Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epith"
• Study of subcutaneous nivolumab monotherapy with or without Recombinant Human Hyaluronidase PH20 (rHuPH20) Ended
  2023-503554-12-00 9 2019-01-09 "lung cancer; kidney cancer; melanoma; liver cancer; colorect"
• A Study of Nivolumab and Nivolumab Combinations in Recurrent and Metastatic Colon Cancer Ended
  2024-516004-42-01 4 2014-05-14 "MSI Negative Colorectal Cancer"
• A Phase 1a/1b Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-5 … Ended
  2024-514704-13-00 1 "Advanced or Metastatic Solid Tumors with KRAS Mutations or A"
• C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors Ended
  2024-517988-23-00 1 "KRAS mutated advanced solid tumors"
• SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study). Ended
  2025-521235-37-00 1 "small cell lung cancer, non-smallcell lung cancer, colorecta"

Showing 49–70 of 70 trials